TY - JOUR
T1 - Impact of Sandimmune, neoral, and prograf on rejection incidence and renal function in primary liver transplant recipients
AU - Van Buren, D.
AU - Payne, J.
AU - Geevarghese, S.
AU - MacDonell, R.
AU - Chapman, W.
AU - Wright, J. K.
AU - Helderman, J. H.
AU - Richie, R.
AU - Pinson, C. W.
PY - 1998
Y1 - 1998
N2 - Following primary liver transplantation, immunosuppression efficacy of Neoral and Prograf was similar and superior to that of Sandimmune. Rejection incidence was statistically increased with Sandimmune therapy. Incidence of hypertension, posttransplant diabetes mellitus, and infectious complications was not statistically different. Although early compromise in renal function was associated with Sandimmune, Neoral and Prograf immunosuppression, no progressive renal dysfunction was identified.
AB - Following primary liver transplantation, immunosuppression efficacy of Neoral and Prograf was similar and superior to that of Sandimmune. Rejection incidence was statistically increased with Sandimmune therapy. Incidence of hypertension, posttransplant diabetes mellitus, and infectious complications was not statistically different. Although early compromise in renal function was associated with Sandimmune, Neoral and Prograf immunosuppression, no progressive renal dysfunction was identified.
UR - http://www.scopus.com/inward/record.url?scp=0031690695&partnerID=8YFLogxK
U2 - 10.1016/S0041-1345(98)00448-5
DO - 10.1016/S0041-1345(98)00448-5
M3 - Article
C2 - 9723299
AN - SCOPUS:0031690695
SN - 0041-1345
VL - 30
SP - 1830
EP - 1832
JO - Transplantation Proceedings
JF - Transplantation Proceedings
IS - 5
ER -